|
DBF4B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03295150211125E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.66810001554086E-09 |
| Normal-vs-Stage2 |
2.037000E-03 |
| Normal-vs-Stage3 |
5.637600E-03 |
| Normal-vs-Stage4 |
8.066300E-02 |
| Stage1-vs-Stage2 |
3.640600E-01 |
| Stage1-vs-Stage3 |
5.899800E-01 |
| Stage1-vs-Stage4 |
6.598400E-01 |
| Stage2-vs-Stage3 |
2.771200E-01 |
| Stage2-vs-Stage4 |
3.760400E-01 |
| Stage3-vs-Stage4 |
9.345000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.02820007852733E-13 |
| Normal-vs-AfricanAmerican |
1.762650E-04 |
| Normal-vs-Asian |
9.458000E-02 |
| Caucasian-vs-AfricanAmerican |
4.856500E-02 |
| Caucasian-vs-Asian |
7.355600E-01 |
| AfricanAmerican-vs-Asian |
2.575400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.14679401927742E-12 |
| Normal-vs-Female |
2.53640000003053E-07 |
| Male-vs-Female |
9.607400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.837700E-04 |
| Normal-vs-Extreme_Weight |
7.45449999950409E-07 |
| Normal-vs-Obese |
2.33680000016889E-07 |
| Normal-vs-Extreme_Obese |
2.056000E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.000200E-01 |
| Normal_Weight-vs-Obese |
1.954620E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.425600E-01 |
| Extreme_Weight-vs-Obese |
1.886380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.126400E-01 |
| Obese-vs-Extreme_Obese |
8.471800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.214300E-04 |
| Normal-vs-Age(41-60Yrs) |
2.22588614207098E-12 |
| Normal-vs-Age(61-80Yrs) |
4.12159999463313E-08 |
| Normal-vs-Age(81-100Yrs) |
6.875800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.037600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.516000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.875560E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.190000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.099600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.754000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.44089209850063E-16 |
| Normal-VS-Type2 PRCC |
1.195980E-01 |
| Normal-VS-KIRP CIMP |
4.718600E-03 |
| Normal-VS-Unclassified PRCC |
1.838370E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.01529895601971E-11 |
| Type1 PRCC-VS-KIRP CIMP |
7.360600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.678800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.855200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.122800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.958800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7184399999981E-05 |
| Normal-vs-N1 |
1.458460E-03 |
| Normal-vs-N2 |
2.072200E-01 |
| N0-vs-N1 |
3.665400E-01 |
| N0-vs-N2 |
7.564200E-01 |
| N1-vs-N2 |
9.011400E-01 |
|
|
